Anna Torres

Summary

Affiliation: Medical University
Country: Poland

Publications

  1. Torres A, Torres K, Paszkowski T, Radej S, Staśkiewicz G, Ceccaroni M, et al. Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report. Int J Gynecol Cancer. 2011;21:8-14 pubmed publisher
  2. Torres A, Torres K, Paszkowski T, Jodłowska Jedrych B, Radomański T, Ksiazek A, et al. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. Tumour Biol. 2011;32:769-76 pubmed publisher
  3. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, et al. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Int J Cancer. 2013;132:1633-45 pubmed publisher
    ..909 (95% CI: 0.789-973) and 0.913 (95% CI: 0.794-0.976), respectively. We conclude that miRNA signatures hold a great promise to become noninvasive biomarkers for early EEC detection and prognosis...
  4. Torres A, Torres K, Wdowiak P, Paszkowski T, Maciejewski R. Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues. Gynecol Oncol. 2013;130:588-94 pubmed publisher
    ..In addition to identifying suitable endogenous controls in EEC, our study presents an appropriate strategy for validation of candidate reference genes for any microRNA qPCR study. ..
  5. Torres A, Kozak J, Korolczuk A, Wdowiak P, Domańska Glonek E, Maciejewski R, et al. In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer. BMC Cancer. 2016;16:822 pubmed
  6. Torres A, Kozak J, Korolczuk A, Wdowiak P, Domańska Glonek E, Maciejewski R, et al. Erratum to: In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer. BMC Cancer. 2016;16:939 pubmed
  7. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, et al. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. BMC Cancer. 2012;12:369 pubmed publisher
    ..In addition, our findings implicate that miRNA signatures can be considered promising biomarkers for early detection and prognosis of endometrioid endometrial carcinoma. ..